Magnesium for neuroprotection in ischaemic stroke: Rationale for use and evidence of effectiveness

CNS Drugs

Volumn 15, Issue 12, 2001, Pages 921-930

  Muir, Keith W ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HEART INFARCTION; HUMAN; NEUROPROTECTION; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 0035666857     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200115120-00002     Document Type: Review

References (89)

1. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man
2. Chronic changes in the brain Mg2+ concentration after forebrain ischemia in the rat
3. Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia
4. Magnesium exchange between blood and cerebrospinal fluid
5. Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients
6. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: A preliminary report
7. Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia
8. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats
9. Accumulation of magnesium in rat brain after intravenously induced hypermagnesemia
10. Magnesium sulfate does not increase ventricular cerebrospinal fluid ionized magnesium concentration in patients with intracranial hypertension
11. Presynaptic actions of adenosine are magnesium-dependent
12. Treatment of experimental focal ischemia in rats with lubeluzole
13. Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat
14. Sodium channel blockade and glutamate release: The mechanism of cerebroprotection by lamotrigine, BW 1003C87 and BW 619C89
15. Magnesium gates glutamate-activated channels in mouse central neurones
16. The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture
17. Effect of magnesium on NMDA mediated toxicity and increases in [Ca2+]i and cGMP in cultured neocortical neurons: Evidence for distinct regulation of different responses
18. Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels
19. Kinetics of the block by intracellular Mg2+ of the NMDA-activated channel in cultured rat neurons
20. Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons
21. Magnesium sulfate treatment decreases N-methyl-D-aspartate receptor binding in the rat brain: An autoradiographic study
22. Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures
23. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats
24. The quantity of calcium that appears to induce neuronal death
25. Calcium antagonists for ischemic stroke: A systematic review
26. Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia
27. Magnesium reduces depolarization time and lesion volume after subarachnoid hemorrhage in the rat
28. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects
29. Evidence that prostacyclin mediates the vascular action of magnesium in humans
30. The effect of magnesium sulfate infusion on systemic and renal prostacyclin production
31. Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique
32. Effect of magnesium sulfate on the vascular actions of norepinephrine and angiotensin II
33. Different effects of Mg2+ on endothelin-1-and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed
34. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats
35. In vivo and in vitro effects of magnesium sulfate in the cerebrovascular bed of the goat
36. Comparison of the anti-constrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries
37. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia
38. The effect of magnesium sulfate on maternal retinal blood flow in preeclampsia: A randomized placebo-controlled study
39. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo-controlled study
40. Favorable hemodynamic effects of magnesium sulfate in preeclampsia
41. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat
42. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia
43. Haemodynamic and endocrine effects of deliberate hypotension with magnesium sulphate for cerebral-aneurysm surgery
44. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo
45. Effect of magnesium sulfate on platelet deposition in rabbits following temporary arterial occlusion with surgical clips
46. Magnesium inhibits platelet activity - An infusion study in healthy volunteers
47. Increased bleeding time after magnesium sulfate infusion
48. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction
49. Recommendations for standards regarding preclinical neuroprotective and restorative drug development
50. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats
51. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia
52. Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat
53. Effects of elevated plasma magnesium versus calcium on cerebral ischemic injury in rats
54. Glucose metabolism and acidosis in the metabolic penumbra of rat brain
55. Mild hypothermia and Mg++ protect against irreversible damage during CNS ischemia
56. Intrathecal magnesium sulfate protects the spinal cord from ischemic injury during thoracic aortic cross-clamping
57. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury
58. NMDA receptor blockade and spinal cord ischemia due to aortic crossclamping in the rat model
59. Effect of magnesium on epileptic foci
60. NMDA receptor complex blockade by oral administration of magnesium: Comparison with MK-801
61. Magnesium is more efficacious than phenytoin in reducing N-methyl-D-aspartate seizures in rats
62. Effects of magnesium sulfate on pentylenetetrazol-induced status epilepticus
63. Mg2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus
64. Effects of magnesium sulfate on brain damage by complete global brain ischemia
65. Magnesium protects against neurological deficit after brain injury
66. Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury
67. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat
68. Preoperative regimens of magnesium facilitate recovery of function and prevent subcortical, atrophy following lesions of the rat sensorimotor cortex
69. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome
70. Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: A comparative phosphorus NMR study
71. A randomised, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke
72. Dose optimization of intravenous magnesium sulfate after acute stroke
73. IMAGES pilot study of intravenous magnesium in acute stroke
74. Infusion of magnesium in patients with acute brain infarction
75. The role of magnesium (Mg) a natural calcium (Ca) antagonist in the treatment of acute ischaemic stroke (clinical study)
76. Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial
77. The Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial: A study of prehospital neuroprotective therapy
78. Systematic review of clinical trials of magnesium for acute stroke
79. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia
80. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial
81. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: An overview of the evidence from randomised trials
82. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia
83. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia
84. Effects of intravenous magnesium in suspected acute myocardial infarction: An overview of the randomised trials
85. Intravenous magnesium sulphate in suspected acute myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
86. Effects of intravenous magnesium sulphate in suspected acute myocardial infarction on acute arrhythmias and long-term outcome
87. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 investigators
88. Tissue plasminogen activator for acute ischemic stroke
89. Neuroprotection in acute ischaemic stroke: A tale of for whom the bell tolls?